Mathew Hickman

Summary

Affiliation: University of Bristol
Country: UK

Publications

  1. pmc Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment
    Jo Kimber
    Department of Social Medicine, University of Bristol, Bristol BS8 2PS
    BMJ 341:c3172. 2010
  2. pmc Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database
    Rosie Cornish
    School of Social and Community Medicine, University of Bristol, Bristol BS8 2PS, UK
    BMJ 341:c5475. 2010
  3. pmc Stronger evidence is needed before accepting that cannabis plays an important role in the aetiology of schizophrenia in the population
    Suzanne H Gage
    School of Social and Community Medicine, University of Bristol, Canynge Hall 39 Whatley Road, Bristol, BS8 1TU MRC Centre for Causal Analyses in Translational Epidemiology Oakfield House 15 23 Oakfield Grove, Bristol, BS8 2BN
    F1000 Med Rep 5:2. 2013
  4. pmc Introducing vaccination against serogroup B meningococcal disease: an economic and mathematical modelling study of potential impact
    Hannah Christensen
    School of Social and Community Medicine, University of Bristol, Bristol, UK
    Vaccine 31:2638-46. 2013
  5. pmc Establishing the Melbourne Injecting Drug User Cohort Study (MIX): rationale, methods, and baseline and twelve-month follow-up results
    Danielle Horyniak
    Centre for Population Health, Burnet Institute, 85 Commercial Rd, Melbourne, VIC 3004, Australia
    Harm Reduct J 10:11. 2013
  6. pmc The Edinburgh Addiction Cohort: recruitment and follow-up of a primary care based sample of injection drug users and non drug-injecting controls
    John Macleod
    Muirhouse Medical Group, 1 Muirhouse Avenue, Edinburgh EH44PL, UK
    BMC Public Health 10:101. 2010
  7. pmc Validating estimates of problematic drug use in England
    Martin Frisher
    Department of Medicines Management, School of Pharmacy, Keele University, ST5 5BG, UK
    BMC Public Health 7:286. 2007
  8. pmc Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales
    A J Sutton
    Centre for Research on Drugs and Health Behaviour, Department of Primary Care and Social Medicine, Imperial College London, London W6 8RP, UK
    BMC Infect Dis 6:93. 2006
  9. pmc Frequency, factors and costs associated with injection site infections: findings from a national multi-site survey of injecting drug users in England
    Vivian Hope
    Centre for Infections, Health Protections Agency, London, UK
    BMC Infect Dis 8:120. 2008
  10. ncbi request reprint Estimating prevalence of injecting drug use: a comparison of multiplier and capture-recapture methods in cities in England and Russia
    Matthew Hickman
    Centre for Research on Drugs and Health Behaviour, CRDHB, Division of Primary Care and Population Sciences, Imperial College, London, UK
    Drug Alcohol Rev 25:131-40. 2006

Detail Information

Publications58

  1. pmc Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment
    Jo Kimber
    Department of Social Medicine, University of Bristol, Bristol BS8 2PS
    BMJ 341:c3172. 2010
    ..To examine survival and long term cessation of injecting in a cohort of drug users and to assess the influence of opiate substitution treatment on these outcomes...
  2. pmc Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database
    Rosie Cornish
    School of Social and Community Medicine, University of Bristol, Bristol BS8 2PS, UK
    BMJ 341:c5475. 2010
    ..To investigate the effect of opiate substitution treatment at the beginning and end of treatment and according to duration of treatment...
  3. pmc Stronger evidence is needed before accepting that cannabis plays an important role in the aetiology of schizophrenia in the population
    Suzanne H Gage
    School of Social and Community Medicine, University of Bristol, Canynge Hall 39 Whatley Road, Bristol, BS8 1TU MRC Centre for Causal Analyses in Translational Epidemiology Oakfield House 15 23 Oakfield Grove, Bristol, BS8 2BN
    F1000 Med Rep 5:2. 2013
    ..However, due to other evidence of the harms of cannabis use, this should not affect the public health message that cannabis can be harmful and that cannabis dependence should be prevented...
  4. pmc Introducing vaccination against serogroup B meningococcal disease: an economic and mathematical modelling study of potential impact
    Hannah Christensen
    School of Social and Community Medicine, University of Bristol, Bristol, UK
    Vaccine 31:2638-46. 2013
    ....
  5. pmc Establishing the Melbourne Injecting Drug User Cohort Study (MIX): rationale, methods, and baseline and twelve-month follow-up results
    Danielle Horyniak
    Centre for Population Health, Burnet Institute, 85 Commercial Rd, Melbourne, VIC 3004, Australia
    Harm Reduct J 10:11. 2013
    ..In this study we specifically sought to recruit a sample of younger, largely out-of-treatment PWID, in order to study the trajectories of their drug use over time...
  6. pmc The Edinburgh Addiction Cohort: recruitment and follow-up of a primary care based sample of injection drug users and non drug-injecting controls
    John Macleod
    Muirhouse Medical Group, 1 Muirhouse Avenue, Edinburgh EH44PL, UK
    BMC Public Health 10:101. 2010
    ..In particular little is known about early life risk factors for later drug injection or about the life course of injection once established including the influence of medical and social interventions...
  7. pmc Validating estimates of problematic drug use in England
    Martin Frisher
    Department of Medicines Management, School of Pharmacy, Keele University, ST5 5BG, UK
    BMC Public Health 7:286. 2007
    ..The estimates were derived from a statistical model using the Multiple Indicator Method (MIM)...
  8. pmc Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales
    A J Sutton
    Centre for Research on Drugs and Health Behaviour, Department of Primary Care and Social Medicine, Imperial College London, London W6 8RP, UK
    BMC Infect Dis 6:93. 2006
    ..In England and Wales, where less than 1% of the population are likely to be injecting drug users (IDUs), approximately 38% of laboratory reports of HBV, and 95% of HCV reports are attributed to injecting drug use...
  9. pmc Frequency, factors and costs associated with injection site infections: findings from a national multi-site survey of injecting drug users in England
    Vivian Hope
    Centre for Infections, Health Protections Agency, London, UK
    BMC Infect Dis 8:120. 2008
    ..This study explores the frequency, factors and costs associated with injection site infections among IDUs in England...
  10. ncbi request reprint Estimating prevalence of injecting drug use: a comparison of multiplier and capture-recapture methods in cities in England and Russia
    Matthew Hickman
    Centre for Research on Drugs and Health Behaviour, CRDHB, Division of Primary Care and Population Sciences, Imperial College, London, UK
    Drug Alcohol Rev 25:131-40. 2006
    ..CRC methods should be preferred as the means of estimating numbers of drug users with multiplier methods being used with caution and only where CRC is not possible...
  11. ncbi request reprint Cannabis and schizophrenia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales
    Matthew Hickman
    Social Medicine, University of Bristol, Canynge Hall, Whiteladies Road, Bristol, UK
    Addiction 102:597-606. 2007
    ..To estimate long-term trends in cannabis use and projections of schizophrenia assuming a causal relation between cannabis use and schizophrenia...
  12. ncbi request reprint Hepatitis C virus (HCV) prevalence, and injecting risk behaviour in multiple sites in England in 2004
    M Hickman
    Social Medicine, University of Bristol, Bristol, UK
    J Viral Hepat 14:645-52. 2007
    ..Geographical variation in HCV prevalence remains poorly explained, but should be the key focus of our surveillance effort. Measures of sharing and their interpretation require greater scrutiny...
  13. ncbi request reprint Increasing the uptake of hepatitis C virus testing among injecting drug users in specialist drug treatment and prison settings by using dried blood spots for diagnostic testing: a cluster randomized controlled trial
    M Hickman
    Department of Social Medicine, University of Bristol, Bristol, UK
    J Viral Hepat 15:250-4. 2008
    ..Additional trials with a larger number of sites are justified, ideally in the context of drug and treatment policies that gave clearer priority (and targets) to infection control and testing...
  14. ncbi request reprint Harm-reduction interventions in injection drug use
    Matthew Hickman
    Social Medicine, University of Bristol, Canynge Hall, Bristol, UK
    Lancet 367:1797-8. 2006
  15. ncbi request reprint Does alcohol increase the risk of overdose death: the need for a translational approach
    Matt Hickman
    Department of Social Medicine, University of Bristol, UK
    Addiction 103:1060-2. 2008
    ..We argue for a translational approach to addiction science, using an important current research question as a case study...
  16. doi request reprint Assessing IDU prevalence and health consequences (HCV, overdose and drug-related mortality) in a primary care trust: implications for public health action
    Mathew Hickman
    Department of Social Medicine, University of Bristol, Canynge Hall, Bristol, UK
    J Public Health (Oxf) 31:374-82. 2009
    ..We report on an exercise to estimate the prevalence of injecting drug use (IDU) and associated harms in a single primary care trust...
  17. doi request reprint If cannabis caused schizophrenia--how many cannabis users may need to be prevented in order to prevent one case of schizophrenia? England and Wales calculations
    Matt Hickman
    Social Medicine, University of Bristol, Canynge Hall, Bristol BS8 2PR, UK
    Addiction 104:1856-61. 2009
    ..We consider how many cannabis users may need to be prevented in order to prevent one case of schizophrenia or psychosis [defined as number needed to prevent (NNP)]...
  18. ncbi request reprint London audit of drug-related overdose deaths: characteristics and typology, and implications for prevention and monitoring
    Matthew Hickman
    Department of Social Medicine, University of Bristol, Bristol, UK
    Addiction 102:317-23. 2007
    ..To describe the circumstances and draft a typology of drug-related overdose deaths...
  19. ncbi request reprint Prevalence of, and risk factors for, hepatitis C virus infection among recent initiates to injecting in London and Glasgow: cross sectional analysis
    A Judd
    Department of Primary Care and Social Medicine, Centre for Research on Drugs and Health Behaviour, Imperial College London, London
    J Viral Hepat 12:655-62. 2005
    ..Comprehensive action is urgently required to reduce the incidence of HCV among injectors...
  20. ncbi request reprint Twenty years of selective hepatitis B vaccination: is hepatitis B declining among injecting drug users in England and Wales?
    A Judd
    MRC Clinical Trials Unit, London, UK
    J Viral Hepat 14:584-91. 2007
    ....
  21. ncbi request reprint Hepatitis B vaccine uptake among injecting drug users in England 1998 to 2004: is the prison vaccination programme driving recent improvements?
    V D Hope
    Centre for Infections, Health Protection Agency, Colindale, London, UK
    J Viral Hepat 14:653-60. 2007
    ....
  22. doi request reprint Measuring risk of HIV and HCV among injecting drug users in the Russian Federation
    Lucy Platt
    Centre for Research on Drugs and Health Behaviour, Public and Environmental Health Research Unit, Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK
    Eur J Public Health 19:428-33. 2009
    ....
  23. pmc Estimates of injecting drug users at the national and local level in developing and transitional countries, and gender and age distribution
    C Aceijas
    Department of Public Health and Policy, Centre for Research on Drugs and Health Behaviour, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK
    Sex Transm Infect 82:iii10-17. 2006
    ..To present and update available national and subnational estimates of injecting drug users (IDUs) in developing/transitional countries, and provide indicative estimates of gender and age distribution...
  24. ncbi request reprint Assessment of the feasibility of conducting population prevalence studies of chronic renal failure according to ethnic group: a survey of clinical biochemistry laboratories in Greater London and south east England
    M Hickman
    Centre for Research on Drugs and Health Behaviour, Social Science and Medicine, Imperial College School of Medicine, London, UK
    Ann Clin Biochem 36:94-8. 1999
    ..Thirty-one laboratories (42%) archived tests within 1 year of entry, which would rule out a retrospective study design. A prospective study is feasible and should be carried out as soon as is practicable...
  25. ncbi request reprint Modelling the impact on Hepatitis C transmission of reducing syringe sharing: London case study
    P Vickerman
    HIVTools Research Group, London School of Hygiene and Tropical Medicine, London, UK
    Int J Epidemiol 36:396-405. 2007
    ..To inform public health action, mathematical modelling is used to explore the possible impact of strategies to decrease syringe sharing...
  26. ncbi request reprint Mapping the prevalence of sickle cell and beta thalassaemia in England: estimating and validating ethnic-specific rates
    M Hickman
    Centre for Research on Drugs and Health Behaviour, ICSM, London
    Br J Haematol 104:860-7. 1999
    ..The long-term solution to monitoring changes in the rates of trait and disease in the population is to introduce a standardized instrument for collecting ethnicity for all community screening programmes...
  27. ncbi request reprint Estimating the prevalence of problem drug use in inner London: a discussion of three capture-recapture studies
    M Hickman
    Centre for Research on Drugs and Health Behaviour, Imperial College School of Medicine, London, UK
    Addiction 94:1653-62. 1999
    ..To provide an evidence base of estimates of the prevalence of problem drug use in inner London...
  28. ncbi request reprint Socio-economic status in childhood and later alcohol use: a systematic review
    Nicola J Wiles
    Academic Unit of Psychiatry, Department of Community Based Medicine, University of Bristol, Bristol, UK
    Addiction 102:1546-63. 2007
    ..To conduct a systematic review of longitudinal studies that examined the association between childhood socio-economic status (SES) and alcohol use in later life...
  29. doi request reprint Changes in HIV prevalence and risk among new injecting drug users in a Russian city of high HIV prevalence
    Lucy Platt
    Centre for Research on Drugs and Health Behaviour, Public and Environmental Health Research Unit, Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom
    J Acquir Immune Defic Syndr 47:623-31. 2008
    ..To measure HIV prevalence and associated risk factors among recent initiates into drug injecting in 2001 and 2004 in Togliatti City, Russian Federation...
  30. ncbi request reprint Association between availability of heroin and methadone and fatal poisoning in England and Wales 1993-2004
    Oliver Morgan
    Department of Primary Care and Social Medicine, Imperial College London, London, UK
    Int J Epidemiol 35:1579-85. 2006
    ..Methadone treatment for heroin addiction in the UK, the 'British system', is unique as it is largely provided by General Practitioners...
  31. pmc Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study
    Ali Judd
    Centre for Research on Drugs and Health Behaviour, Department of Primary Care and Social Medicine, Imperial College London, London W6 8RP
    BMJ 330:24-5. 2005
  32. ncbi request reprint Estimating long-term trends in the incidence and prevalence of opiate use/injecting drug use and the number of former users: back-calculation methods and opiate overdose deaths
    Daniela de Angelis
    Health Protection Agency Statistics Unit, London, United Kingdom
    Am J Epidemiol 160:994-1004. 2004
    ..In practice, its full potential will be realized only once better information on the process of stopping opiate use/IDU becomes available and more precise estimates of current and historical overdose mortality are obtained...
  33. pmc Injecting drug use in Brighton, Liverpool, and London: best estimates of prevalence and coverage of public health indicators
    Matthew Hickman
    CRDHB, Social Science and Medicine, Imperial College, Charing Cross Campus, St Dunstans Road, London SW6 1RQ, UK
    J Epidemiol Community Health 58:766-71. 2004
    ..To estimate the prevalence of injecting drug use (IDU) in three cities in England and to measure the coverage of key public health indicators...
  34. ncbi request reprint HIV prevalence among injecting drug users in England and Wales 1990 to 2003: evidence for increased transmission in recent years
    Vivian D Hope
    Health Protection Agency, Centre for Infections, 61 Colindale Av, London NW9 5EQ, UK
    AIDS 19:1207-14. 2005
    ..To describe trends in HIV prevalence among injecting drug users in England and Wales between 1990 and 2003...
  35. ncbi request reprint Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia
    Tim Rhodes
    The Centre for Research on Drugs and Health Behaviour and Unit for International Public Health and Development, Imperial College, London, UK
    Int J STD AIDS 16:749-54. 2005
    ..There is an urgent need to maximize syringe distribution coverage, develop health promotion targeting HCV prevention for IDUs, and improve access among IDUs to treatments for HIV and HCV infection...
  36. ncbi request reprint Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi-city study
    Tim Rhodes
    Centre for Research on Drugs and Health Behaviour and Unit for International Public Health and Development, Imperial College London, UK
    Addiction 101:252-66. 2006
    ..To estimate the prevalence of HIV, hepatitis C virus (HCV) and syphilis in injecting drug users (IDUs) in Russia...
  37. ncbi request reprint Trends in drug overdose deaths in England and Wales 1993-98: methadone does not kill more people than heroin
    Matthew Hickman
    Centre for Research on Drugs and Health Behaviour, Social Science and Medicine, Imperial College, London, UK
    Addiction 98:419-25. 2003
    ..To test the hypothesis that methadone is responsible for a greater increase in overdose deaths than heroin, and causes proportionally more overdose deaths than heroin at weekends...
  38. ncbi request reprint Access and coverage of needle and syringe programmes (NSP) in Central and Eastern Europe and Central Asia
    Carmen Aceijas
    Centre for Research on Drugs and Health Behaviour CRDHB, London School of Hygiene and Tropical Medicine LSHTM, Department of Public Health and Policy, London, UK
    Addiction 102:1244-50. 2007
    ..To estimate access, activity and coverage of needle and syringe programmes (NSP) in Central and Eastern Europe and Central Asia...
  39. pmc Drug-related mortality and fatal overdose risk: pilot cohort study of heroin users recruited from specialist drug treatment sites in London
    Matthew Hickman
    Centre for Research on Drugs and Health Behaviour, Social Science and Medicine, Imperial College, London
    J Urban Health 80:274-87. 2003
    ..The pilot study showed that these studies are feasible and ethical, and that specialist drug agencies could have a vital role to play in the monitoring of drug-related mortality...
  40. ncbi request reprint The prevalence of injecting drug use in a Russian city: implications for harm reduction and coverage
    Lucy Platt
    Department of Primary Care and Social Medicine, Imperial College Faculty of Medicine, University of London, London, UK
    Addiction 99:1430-8. 2004
    ..This study sought to estimate the prevalence of injecting drug users (IDU) in Togliatti city and to examine the implications of these estimates for HIV prevalence and harm reduction...
  41. ncbi request reprint Explosive spread and high prevalence of HIV infection among injecting drug users in Togliatti City, Russia
    Tim Rhodes
    Department of Social Science and Medicine, Imperial College Faculty of Medicine, University of London, London, UK
    AIDS 16:F25-31. 2002
    ..To establish the prevalence of antibodies to HIV (anti-HIV) and associated risk factors among injecting drug users (IDU) in Togliatti City, Samara Oblast, Russian Federation...
  42. ncbi request reprint Over a decade of syringe exchange: results from 1997 UK survey
    James Parsons
    Criminal Policy Research Unit, South Bank University, London
    Addiction 97:845-50. 2002
    ..To describe syringe exchange provision in the United Kingdom...
  43. ncbi request reprint Early exposure to marijuana and risk of later drug use
    John Macleod
    JAMA 290:329-30; author reply 330-1. 2003
  44. ncbi request reprint Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots
    Ali Judd
    Centre for Research on Drugs and Health Behaviour, Department of Social Science and Medicine, Faculty of Medicine, Imperial College London, United Kingdom
    J Med Virol 71:49-55. 2003
    ..In addition, dried blood spot specimens may be useful for surveillance and could be employed as a first line diagnostic specimen...
  45. ncbi request reprint Effectiveness of preventing frequent cannabis use among young people in improving educational achievement: eradicating frequent cannabis use among adolescents could reduce school dropout by 3%
    Matthew Hickman
    Addiction 99:650-1; author reply 651-2. 2004
  46. ncbi request reprint Transmission of hepatitis C--are noninjecting cocaine users at risk?
    Ali Judd
    Subst Use Misuse 37:573-5. 2002
  47. ncbi request reprint Antiretroviral treatment for injecting drug users in developing and transitional countries 1 year before the end of the "Treating 3 million by 2005. Making it happen. The WHO strategy" ("3 by 5")
    Carmen Aceijas
    Centre for Research on Drugs and Health Behaviour CRDHB, Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK
    Addiction 101:1246-53. 2006
    ..To describe and estimate the availability of antiretroviral treatment (ART) to injecting drug users (IDUs) in developing and transitional countries...
  48. ncbi request reprint Trends in overdose deaths from drug misuse in Europe: what do the data tell us?
    Oliver Morgan
    Addiction 103:699-700. 2008
  49. ncbi request reprint Public injecting and the need for 'safer environment interventions' in the reduction of drug-related harm
    Tim Rhodes
    Centre for Research on Drugs and Health Behaviour, Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, UK
    Addiction 101:1384-93. 2006
    ..Yet the quality of evidence on public injecting and related viral risk is variable, and is lacking in many countries such as the United Kingdom...
  50. pmc Methods to recruit hard-to-reach groups: comparing two chain referral sampling methods of recruiting injecting drug users across nine studies in Russia and Estonia
    Lucy Platt
    Centre for Research on Drugs and Health Behaviour, Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK
    J Urban Health 83:i39-53. 2006
    ....
  51. ncbi request reprint Commentary: understanding pathways to cannabis use and from use to harm
    John Macleod
    Department of Primary Care and General Practice, Primary Care Clinical Sciences and Learning Centre Building, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
    Int J Epidemiol 35:680-2. 2006
  52. ncbi request reprint Model projections on the required coverage of syringe distribution to prevent HIV epidemics among injecting drug users
    Peter Vickerman
    HIVTools Research Group, London School of Hygiene and Tropical Medicine, London, UK
    J Acquir Immune Defic Syndr 42:355-61. 2006
    ..Although syringe distribution is effective in preventing HIV transmission among injecting drug users (IDUs), there is little evidence on the required coverage to substantially reduce HIV transmission...
  53. ncbi request reprint Does cannabis use cause schizophrenia?
    John Macleod
    Lancet 367:1055. 2006
  54. ncbi request reprint Capturing crack cocaine use: estimating the prevalence of crack cocaine use in London using capture-recapture with covariates
    Vivian D Hope
    Centre for Research on Drugs and Health Behaviour, Imperial College London, London, UK
    Addiction 100:1701-8. 2005
    ..To estimate the prevalence of crack cocaine use in 12 London Boroughs (and London as a whole)...
  55. ncbi request reprint Reporting bias and self-reported drug use
    John Macleod
    Addiction 100:562-3. 2005
  56. ncbi request reprint Cannabis and psychosis
    John Macleod
    Lancet 370:1539; author reply 1539-40. 2007
  57. ncbi request reprint Global overview of injecting drug use and HIV infection among injecting drug users
    Carmen Aceijas
    Centre for Research on Drugs and Health Behaviour CRDHB, Department of Primary Care and Social Medicine, Imperial College, London, UK
    AIDS 18:2295-303. 2004
    ..To provide global estimates of the prevalence of injecting drug use (IDU) and HIV prevalence among IDU, in particular to provide estimates for developing and transitional countries...
  58. ncbi request reprint Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study
    Marina Davoli
    Department of Epidemiology, Rome, Italy
    Addiction 102:1954-9. 2007
    ..Specialist drug treatment is critical to overdose prevention; methadone maintenance is effective, but we lack evidence for other modalities. We evaluate the impact of a range of treatments for opiate dependence on overdose mortality...